Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chroman. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110698456A reveals a cost-effective synthesis of 2,3-dihydrothiochromen-4-one using acrylic acid, offering significant supply chain advantages for pharmaceutical intermediate manufacturers.
This patent reveals a base-catalyzed route for benzopyran synthesis offering high yields and mild conditions suitable for scalable pharmaceutical intermediate manufacturing processes globally.
Patent CN116640108A reveals metal-free synthesis for high-purity 2-vinyl chroman compounds ensuring cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Novel peptide coupling method ensures high purity Nebivolol intermediate with reduced racemization risks for scalable pharmaceutical manufacturing.
Patent CN103087028A details a robust Grignard-Suzuki route for Nebivolol intermediates, offering cost reduction and scalable chiral chroman manufacturing for global supply chains.
Patent CN115286608A reveals a high-yield, base-catalyzed route for benzopyran compounds, offering cost reduction in pharmaceutical intermediate manufacturing and superior functional group tolerance.
Patent CN114222734B reveals copper-catalyzed route for chromanone derivatives offering high purity and cost efficiency for pharmaceutical intermediates manufacturing supply chains.
Novel Bronsted acid-catalyzed route for spiro-oxindoles using 2,5-dimethylfuran. High yield, metal-free, scalable pharmaceutical intermediate manufacturing.
Patent CN106831691A reveals iron-catalyzed oxidation for isochroman-4-one. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN120349297A reveals photocatalytic synthesis for high-purity intermediates. Enables cost reduction and scalable supply chain solutions.
Novel synthesis route for pharmaceutical intermediates reducing costs and improving supply chain reliability for global buyers seeking high purity materials.
Patent CN102603693A details a novel synthesis replacing expensive catalysts with aluminum chloride, offering significant cost reduction and improved yields for pharmaceutical intermediates.
Novel acid-catalyzed cyclization route for high-purity isochroman derivatives offering cost reduction and scalable manufacturing for pharma intermediates.
Patent CN116003369A reveals a novel Sc(OTf)3-catalyzed hydrogen migration strategy for efficient spirochroman synthesis, offering significant cost and supply chain advantages for pharmaceutical intermediate manufacturing.
Novel one-pot cascade synthesis of tetrahydroquinoline chroman polycyclic compounds. Efficient route for antitumor drug intermediates with mild conditions.
Patent CN112794837B reveals a high-yield isochroman synthesis using TPSCA. This method offers mild conditions and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN116444503A details a rhodium-catalyzed route to chroman derivatives using pyridine triazoles, offering mild conditions and high purity for pharmaceutical manufacturing.
Patent CN112898259A reveals a metal-free hydrogenation method for chiral chromanones, offering high purity and reduced toxicity for pharmaceutical supply chains.
Novel Pd-catalyzed C-H activation route for benzopyran-3-ols. High yield, mild conditions. Cost-effective manufacturing for pharma intermediates.
Patent CN110330475A reveals mild carbocation-mediated synthesis. Enables cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing globally.